The $15bn ‘viral’ AI start-up changing how American doctors treat patients

OpenEvidence, a $15 billion AI startup, is revolutionizing patient care in the US with its chatbot, reportedly used by two-thirds of American physicians. The tool's ad-driven model has sparked discussions about the future of healthcare delivery and patient outcomes. While it promises to streamline medical processes, critics are questioning its long-term impact on personalized patient care and ethical advertising practices in medicine. This development underscores a broader shift in how technology is integrated into healthcare.